Senores Pharmaceuticals appoints Gautam Shah as President of US operations
May 06, 2025 | Tuesday | News
Shah brings over three decades of experience in the pharmaceutical industry
The US subsidiary of Senores Pharmaceuticals Limited (SPL), Havix Group Inc. D/B/A Aavis Pharmaceuticals, has announced the appointment of Gautam Shah as President of US operations. This strategic move underscores the company's commitment to expanding its footprint in the regulated US market.
Shah brings over three decades of experience in the pharmaceutical industry, including 10 years in India and 20 years in the United States. His illustrious career includes senior roles at renowned pharmaceutical companies such as Cipla and Sun Pharma in India and Sun Pharma, Zydus Lifesciences, Intas Pharmaceuticals, Dow Corning Corp., and Med-Pharmex in the US. His expertise spans quality assurance, compliance, operations management, manufacturing, and leadership.
Shah holds a bachelor's degree in pharmacy, a postgraduate diploma in business administration, and is a certified Six Sigma Black Belt. As President of US Operations, he will lead the entire group’s US operations and will be instrumental in future expansion.
